Charts Oramed Pharmaceuticals Inc. Deutsche Boerse AG
Stocks
OJU1
US68403P2039
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
09:02:26 31/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 4.280 EUR | -0.81% |
|
+5.42% | +77.45% |
| 08-31 | Lifeward Names Josh Hexter as Interim CEO and Rami Aviram as CFO | MT |
| 08-11 | Oramed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Stock exchange
Deutsche Boerse AG
OJU1 4.280 €
-0.81%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| ORMP | 5.020USD | -0.20% | 1.22M $ | |
CBOE
| ORMP | 5.030USD | -.--% | 57.14K $ | |
|
TEL AVIV STOCK EXCHANGE
| ORMP | 1,493.00ILa | -0.47% | 8.56M ILa | |
|
Tradegate
| OJU1 | 4.330EUR | -0.35% | 653.83 € | |
|
Deutsche Boerse AG
| OJU1 | 4.280EUR | -0.81% | 0 € | |
|
Börse Stuttgart
| OJU1 | 4.300EUR | +0.23% | 0 € | |
|
Boerse Muenchen
| OJU1 | 4.290EUR | -2.17% | 0 € |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ORMP Stock
- OJU1 Stock
- Charts Oramed Pharmaceuticals Inc.
Select your edition
All financial news and data tailored to specific country editions
